191 related articles for article (PubMed ID: 27481239)
1. A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection.
Narra HP; Shubitz LF; Mandel MA; Trinh HT; Griffin K; Buntzman AS; Frelinger JA; Galgiani JN; Orbach MJ
Infect Immun; 2016 Oct; 84(10):3007-16. PubMed ID: 27481239
[TBL] [Abstract][Full Text] [Related]
2. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
3. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
[TBL] [Abstract][Full Text] [Related]
4. The WOPR family protein Ryp1 is a key regulator of gene expression, development, and virulence in the thermally dimorphic fungal pathogen Coccidioides posadasii.
Mandel MA; Beyhan S; Voorhies M; Shubitz LF; Galgiani JN; Orbach MJ; Sil A
PLoS Pathog; 2022 Apr; 18(4):e1009832. PubMed ID: 35385558
[TBL] [Abstract][Full Text] [Related]
5. Urease produced by Coccidioides posadasii contributes to the virulence of this respiratory pathogen.
Mirbod-Donovan F; Schaller R; Hung CY; Xue J; Reichard U; Cole GT
Infect Immun; 2006 Jan; 74(1):504-15. PubMed ID: 16369007
[TBL] [Abstract][Full Text] [Related]
6. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
[TBL] [Abstract][Full Text] [Related]
7. Δcps1 vaccine protects dogs against experimentally induced coccidioidomycosis.
Shubitz LF; Robb EJ; Powell DA; Bowen RA; Bosco-Lauth A; Hartwig A; Porter SM; Trinh H; Moale H; Bielefeldt-Ohmann H; Hoskinson J; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2021 Nov; 39(47):6894-6901. PubMed ID: 34696935
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
Herr RA; Hung CY; Cole GT
Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
[TBL] [Abstract][Full Text] [Related]
9. Vaccine Protection of Mice With Primary Immunodeficiencies Against Disseminated Coccidioidomycosis.
Powell DA; Hsu AP; Butkiewicz CD; Trinh HT; Frelinger JA; Holland SM; Galgiani JN; Shubitz LF
Front Cell Infect Microbiol; 2021; 11():790488. PubMed ID: 35071044
[TBL] [Abstract][Full Text] [Related]
10. Extracellular ammonia at sites of pulmonary infection with Coccidioides posadasii contributes to severity of the respiratory disease.
Wise HZ; Hung CY; Whiston E; Taylor JW; Cole GT
Microb Pathog; 2013; 59-60():19-28. PubMed ID: 23583291
[TBL] [Abstract][Full Text] [Related]
11. Proper Care and Feeding of Coccidioides: A Laboratorian's Guide to Cultivating the Dimorphic Stages of C. immitis and C. posadasii.
Mead HL; Van Dyke MCC; Barker BM
Curr Protoc Microbiol; 2020 Sep; 58(1):e113. PubMed ID: 32894648
[TBL] [Abstract][Full Text] [Related]
12. Coccidioides posadasii infection alters the expression of pulmonary surfactant proteins (SP)-A and SP-D.
Awasthi S; Magee DM; Coalson JJ
Respir Res; 2004 Dec; 5(1):28. PubMed ID: 15588319
[TBL] [Abstract][Full Text] [Related]
13. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.
Shubitz L; Peng T; Perrill R; Simons J; Orsborn K; Galgiani JN
Infect Immun; 2002 Jun; 70(6):3287-9. PubMed ID: 12011027
[TBL] [Abstract][Full Text] [Related]
14. Differences in expression of cell surface co-stimulatory molecules, Toll-like receptor genes and secretion of IL-12 by bone marrow-derived dendritic cells from susceptible and resistant mouse strains in response to Coccidioides posadasii.
Awasthi S; Magee DM
Cell Immunol; 2004; 231(1-2):49-55. PubMed ID: 15919369
[TBL] [Abstract][Full Text] [Related]
15. Differences in Host Innate Responses among Coccidioides Isolates in a Murine Model of Pulmonary Coccidioidomycosis.
Lewis ER; David VR; Doyle AL; Rajabi K; Kiefer JA; Pirrotte P; Barker BM
Eukaryot Cell; 2015 Oct; 14(10):1043-53. PubMed ID: 26275879
[TBL] [Abstract][Full Text] [Related]
16. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
[TBL] [Abstract][Full Text] [Related]
17. A Chronic Murine Disease Model of Coccidioidomycosis Using Coccidioides posadasii, Strain 1038.
Shubitz LF; Powell DA; Butkiewicz CD; Lewis ML; Trinh HT; Frelinger JA; Orbach MJ; Galgiani JN
J Infect Dis; 2021 Jan; 223(1):166-173. PubMed ID: 32658292
[TBL] [Abstract][Full Text] [Related]
18. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
Xue J; Hung CY; Yu JJ; Cole GT
Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii.
Awasthi S; Awasthi V; Magee DM; Coalson JJ
J Immunol; 2005 Sep; 175(6):3900-6. PubMed ID: 16148136
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of TLR4-defective C3H/HeJ mice to Coccidioides posadasii infection.
Awasthi S
Med Mycol; 2010 May; 48(3):470-5. PubMed ID: 20370361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
